RA Capital Management, L.P. 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS | RA Capital Management, L.P. | 5,105,213 9.000% | 692,063 (+15.68%) | Filing |
| 2024-02-12 4:17 pm Purchase | 2024-02-01 | 13G | Astria Therapeutics, Inc. ATXS | RA Capital Management, L.P. | 4,413,150 8.100% | 4,413,150 (New Position) | Filing |
| 2022-11-14 4:43 pm Sale | 2022-11-14 | 13G | Astria Therapeutics, Inc. ATXS | RA Capital Management, L.P. | 0 0.000% | -1,262,193 (Position Closed) | Filing |
| 2022-02-14 4:11 pm Purchase | 2021-12-31 | 13G | Astria Therapeutics, Inc. ATXS | RA Capital Management, L.P. | 1,262,193 9.700% | 1,262,193 (New Position) | Filing |